Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Myriad Genetics (MYGN) Other Non Operating Income (2016 - 2025)

Myriad Genetics has reported Other Non Operating Income over the past 17 years, most recently at $400000.0 for Q4 2025.

  • Quarterly Other Non Operating Income rose 33.33% to $400000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $800000.0 through Dec 2025, down 27.27% year-over-year, with the annual reading at $800000.0 for FY2025, 27.27% down from the prior year.
  • Other Non Operating Income was $400000.0 for Q4 2025 at Myriad Genetics, roughly flat from $400000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $120.6 million in Q3 2021 and troughed at -$2.4 million in Q2 2023.
  • The 5-year median for Other Non Operating Income is $100000.0 (2022), against an average of $8.1 million.
  • Year-over-year, Other Non Operating Income skyrocketed 7637.5% in 2021 and then plummeted 2500.0% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $120.6 million in 2021, then tumbled by 99.59% to $500000.0 in 2022, then plummeted by 240.0% to -$700000.0 in 2023, then skyrocketed by 142.86% to $300000.0 in 2024, then soared by 33.33% to $400000.0 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Other Non Operating Income are $400000.0 (Q4 2025), $400000.0 (Q3 2025), and -$100000.0 (Q2 2025).